Advertisement

Topics

Amgen, Allergan get FDA nod for biosimilar Herceptin

14:23 EDT 14 Jun 2019 | Drug Store News

pharmacy/amgen-allergan-get-fda-nod-for-biosimilar-herceptin/">

The FDA approval of biosimilar Herceptin provides an additional treatment option for patients across three types of cancer.

Read More

Original Article: Amgen, Allergan get FDA nod for biosimilar Herceptin

NEXT ARTICLE

More From BioPortfolio on "Amgen, Allergan get FDA nod for biosimilar Herceptin"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...